# FDA 483 - Chongqing Kangle Pharmaceutical Co., Ltd - July 23, 2018

Source: https://www.globalkeysolutions.net/records/483/chongqing-kangle-pharmaceutical-co-ltd/d8415090-ab91-4e96-82df-e1fd011c3335

> FDA 483 for Chongqing Kangle Pharmaceutical Co., Ltd on July 23, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Chongqing Kangle Pharmaceutical Co., Ltd
- Inspection Date: 2018-07-23
- Product Type: drugs
- Office Name: Office of Biological Products Operations - Division I

## Related Documents

- [483 - 2018-07-23](https://www.globalkeysolutions.net/records/483/chongqing-kangle-pharmaceutical-co-ltd/e17e0324-01c8-4011-b4aa-c0b68cf21f7d)

## Related Officers

- [Dennis Cantellops Paite](https://www.globalkeysolutions.net/people/dennis-cantellops-paite/3336bbb8-8520-4a8a-9085-76e7a55ca773)

Company: https://www.globalkeysolutions.net/companies/chongqing-kangle-pharmaceutical-co-ltd/10ee20e7-7e03-4bf3-835f-53e9c3c8ebfc

Office: https://www.globalkeysolutions.net/offices/office-of-biological-products-operations-division-i/49c53dac-7724-4c8c-8708-4f5779ea69c1